NRX Pharmaceuticals, Inc. Share Price
NRXPNRX Pharmaceuticals, Inc. Stock Performance
Open $1.76 | Prev. Close $1.84 | Circuit Range N/A |
Day Range $1.73 - $1.84 | Year Range $1.58 - $3.83 | Volume 16,196 |
Average Traded $1.80 |
NRX Pharmaceuticals, Inc. Share Price Chart
About NRX Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression. The company has a license agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd.; Apkarian Technologies; development and license agreement with Glytech, LLC; and Sarah Herzog Memorial Hospital. NRx Pharmaceuticals, Inc. was founded in 2015 and is based in Wilmington, Delaware.
NRX Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
17-Feb-26 | $1.76 | $1.83 | +0.00% |
17-Feb-26 | $1.76 | $1.83 | +1.67% |
13-Feb-26 | $1.78 | $1.80 | +4.35% |
12-Feb-26 | $1.84 | $1.73 | -5.22% |
11-Feb-26 | $1.85 | $1.82 | -2.67% |
10-Feb-26 | $1.95 | $1.87 | -6.27% |
09-Feb-26 | $1.88 | $2.00 | +5.00% |